CC BY 4.0 · Klin Monbl Augenheilkd 2024; 241(06): 768-771
Effective Focal Laser Photocoagulation for Persistent Central Serous Chorioretinopathy: A Forgotten Technique
Effektive fokale Laser-Photokoagulation bei persistierender zentraler seröser Chorioretinopathie: eine vergessene Technik
Peter Kiraly
1
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom of Great Britain and Northern Ireland
2
Nuffield Laboratory of Ophthalmology, University of Oxford Nuffield Laboratory of Ophthalmology, Oxford, United Kingdom of Great Britain and Northern Ireland
› Author Affiliations
References
1
Daruich A,
Matet A,
Dirani A.
et al.
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 2015; 48: 82-118
2
Wang M,
Munch IC,
Hasler PW.
et al.
Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126-145
3
Kiraly P,
Smrekar J,
Mekjavić PJ.
Visual function during and after an acute central serous chorioretinopathy episode. Doc Ophthalmol 2022; 145: 27-35
4
Mrejen S,
Balaratnasingam C,
Kaden TR.
et al.
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. Ophthalmology 2019; 126: 576-588
5
Burumcek E,
Mudun A,
Karacorlu S.
et al.
Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997; 104: 616-622
6
Slusher MM.
Krypton red laser photocoagulation in selected cases of central serous chorioretinopathy. Retina 1986; 6: 81-84
7
van Rijssen TJ,
van Dijk EHC,
Yzer S.
et al.
Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog Retin Eye Res 2019; 73: 100770
8
Yap EY,
Robertson DM.
The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996; 114: 689-692
9
van Dijk EHC,
Fauser S,
Breukink MB.
et al.
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial. Ophthalmology 2018; 125: 1547-1555
10
Bousquet E,
Zhao M,
Daruich A.
et al.
Mineralocorticoid antagonists in the treatment of central serous chorioretinopathy: Review of the pre-clinical and clinical evidence. Exp Eye Res 2019; 187: 107754
11
van Rijssen TJ,
van Dijk EHC,
Tsonaka R.
et al.
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial. Am J Ophthalmol 2022; 233: 101-110
12
Lotery A,
Sivaprasad S,
OʼConnell A.
et al.
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lancet 2020; 395: 294-303
13
Raizada K,
Naik M.
Photodynamic Therapy for the Eye. Treasure Island (FL): StatPearls Publishing; 2023
14
Sirks MJ,
van Dijk EHC,
Rosenberg N.
et al.
Clinical impact of the worldwide shortage of verteporfin (Visudyne) on ophthalmic care. Acta Ophthalmol 2022; 100: e1522-e1532
15
Battaglia Parodi M,
Arrigo A,
Iacono P.
et al.
Central Serous Chorioretinopathy: Treatment with Laser. Pharmaceuticals (Basel) 2020; 13: 359
16
Inomata H.
Wound healing after xenon arc photocoagulation in the rabbit retina. Identification of the proliferating cells in the lesion by light and electron microscopic autoradiography using 3 h-tymidine. Ophthalmologica 1975; 170: 462-474
17
Leaver P,
Williams C.
Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979; 63: 674-677
18
Khosla PK,
Rana SS,
Tewari HK.
et al.
Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers 1997; 28: 693-697
19
Robertson DM,
Ilstrup D.
Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457-466
20
Lim JW,
Kang SW,
Kim YT.
et al.
Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy. Br J Ophthalmol 2011; 95: 514-517
21
Russo A,
Turano R,
Morescalchi F.
et al.
Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2017; 255: 1141-1148
22
van Dijk EHC,
Boon CJF.
Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula. Prog Retin Eye Res 2021; 84: 100955
23
Fernández-Vigo JI,
Rego-Lorca D,
Moreno-Morillo FJ.
et al.
Intervortex Venous Anastomosis in the Macula in Central Serous Chorioretinopathy Imaged by En Face Optical Coherence Tomography. J Clin Med 2023; 12: 2088
24
Singh SR,
Goté JT,
Chhablani J.
Randomized controlled trials in central serous chorioretinopathy: A review. Eye (Lond) 2023; 37: 3306-3312
25
Mudvari SS,
Goff MJ,
Fu AD.
et al.
The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina 2007; 27: 1168-1173
26
Matsunaga H,
Nangoh K,
Uyama M.
et al.
[Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy]. Nihon Ganka Gakkai Zasshi 1995; 99: 460-468
27
Schatz H,
Yannuzzi LA,
Gitter KA.
Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? 1975. Retina 2012; 32 (Suppl. 1) OP893-OP906
